Intelligent Medicine

Breaking Ground in Biotech: The Role of AI and Gene Editing, Part 2

Informações:

Sinopsis

Dr. Hoffman continues his conversation with physician and molecular biologist Dr. Adrian Woolfson, co-founder of Genyro, a biotechnology company specializing in synthetic genome design and construction, and author of “On the Future of Species: Authoring Life by Means of Artificial Biological Intelligence.”